Press Release: NeoGenomics : NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO), a leading provider of oncology testing services, today announced the analytical
Read full article »
NeoGenomics is a Florida-based clinical laboratory that provides services including oncology genetic testing, contract research and drug development for physicians.
Read more